title: Patterns of care study of breast-conserving therapy in Japan: comparison of the treatment process between 1995 1997 and 1999 2001 surveys.
abstract: BACKGROUND
  The Japan Patterns of Care Study (JPCS) conducted two national surveys to identify changes associated with the treatment process of care for patients undergoing breast-conserving therapy (BCT). Between the two national surveys, the Japanese Breast Cancer Society published its treatment guideline for BCT.
  
  
  METHODS
  The first survey collected data on 865 patients treated between 1995 and 1997 (JPCS-1), and the second on 746 patients treated between1999 and 2001 (JPCS-2) by extramural audits.
  
  
  RESULTS
  There was a shift to an older age distribution in JPCS-2 compared with JPCS-1. In JPCS-2, the average patient age was 53.9 compared with 51.5 in JPCS-1 (P < 0.001). There was a reduction in the extent of breast surgery and the proportion of the patients who received quadrantectomy was 57.0% in JPCS-1 and 30.3% in JPCS-2 (P < 0.001). In JPCS-2, a cast or shell for immobilization was used at a significantly higher rate of 52.9% compared with 32.6% for JPCS-1 (P < 0.001). The rate of boost irradiation was increased in JPCS-2, especially for patients with a positive surgical margin; it was significantly increased to 83.5% in JPCS-2 compared with 53.9% in JPCS-1 (P < 0.001).
  
  
  CONCLUSIONS
  The second survey revealed a rapid change in the trend of the treatment of BCT in Japan and represented high compliance of the treatment guideline for BCT published by the Japanese Breast Cancer Society (JBCS) in 1999.
authors.affiliation: Department of Radiation Oncology and Image-applied Therapy Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan. chikay@kuhp.kyoto-u.ac.jp
authors.forename: Chikako
authors.initials: C
authors.lastname: Yamauchi
authors.forename: Michihide
authors.initials: M
authors.lastname: Mitsumori
authors.forename: Heitetsu
authors.initials: H
authors.lastname: Sai
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Imagunbai
authors.forename: Yoshiharu
authors.initials: Y
authors.lastname: Negoro
authors.forename: Yoshihide
authors.initials: Y
authors.lastname: Sasaki
authors.forename: Masahiro
authors.initials: M
authors.lastname: Hiraoka
authors.forename: Naoto
authors.initials: N
authors.lastname: Shikama
authors.forename: Shigeru
authors.initials: S
authors.lastname: Sasaki
authors.forename: Hideki
authors.initials: H
authors.lastname: Takegawa
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Inoue
authors.forename: Teruki
authors.initials: T
authors.lastname: Teshima
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery*; D017024:Chemotherapy, Adjuvant; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007564:Japan; D008207:Lymphatic Metastasis; D015412:Mastectomy, Segmental / Q000706:statistics & numerical data*; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D016685:Mitomycin / Q000008:administration & dosage; D008942:Mitoxantrone / Q000008:administration & dosage; D009367:Neoplasm Staging; D017239:Paclitaxel / Q000008:administration & dosage; D011159:Population Surveillance; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D018714:Radiotherapy, Adjuvant; D013629:Tamoxifen / Q000627:therapeutic use; D014747:Vinblastine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D013629:Tamoxifen; D016685:Mitomycin; D014750:Vincristine; D014747:Vinblastine; D004317:Doxorubicin; D003520:Cyclophosphamide; D008942:Mitoxantrone; D017239:Paclitaxel; D008727:Methotrexate